neuroblastoma

Hemorrhagic colitis developed during proton therapy after intensive neuroblastoma treatment

A child developed hemorrhagic colitis after only 12.6 Gy(RBE), suggesting preceding intensive systemic therapy may increase bowel vulnerability.